XML 47 R36.htm IDEA: XBRL DOCUMENT v2.4.0.6
Restatement (Tables)
9 Months Ended
Sep. 30, 2012
Restatement  
Schedule of effects of restatement on the consolidated statements of operations

 

 

 

 

For the three months ended September 30, 2011

 

For the nine months ended September 30, 2011

 

 

 

Previously

 

 

 

 

 

Previously

 

 

 

 

 

 

 

Reported

 

Adjustments

 

Restated

 

Reported

 

Adjustments

 

Restated

 

Revenue

 

 

 

 

 

 

 

 

 

 

 

 

 

Medical equipment outsourcing

 

$

74,787

 

$

(5,785

)

$

69,002

 

$

214,873

 

$

(9,714

)

$

205,159

 

Technical and professional services

 

13,852

 

 

13,852

 

36,083

 

 

36,083

 

Medical equipment sales and remarketing

 

6,490

 

 

6,490

 

17,972

 

 

17,972

 

Total revenues

 

95,129

 

(5,785

)

89,344

 

268,928

 

(9,714

)

259,214

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of Sales

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of medical equipment outsourcing

 

29,599

 

(5,785

)

23,814

 

82,499

 

(9,714

)

72,785

 

Cost of technical and professional services

 

10,540

 

 

10,540

 

26,650

 

 

26,650

 

Cost of medical equipment sales and remarketing

 

5,215

 

 

5,215

 

14,115

 

 

14,115

 

Medical equipment depreciation

 

17,006

 

 

17,006

 

51,678

 

 

51,678

 

Total costs of medical equipment outsourcing, technical and professional services and medical equipment sales and remarketing

 

62,360

 

(5,785

)

56,575

 

174,942

 

(9,714

)

165,228

 

Gross margin

 

32,769

 

 

32,769

 

93,986

 

 

93,986

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Provision (benefit) for income taxes

 

(145

)

 

(145

)

(7,451

)

1,041

 

(6,410

)

Consolidated net loss

 

(5,586

)

 

(5,586

)

(13,003

)

(1,041

)

(14,044

)

Net loss attributable to Universal Hospital Services, Inc.

 

(5,745

)

 

(5,745

)

(13,300

)

(1,041

)

(14,341

)

Schedule of effects of restatement on the consolidated statements of cash flows

 

 

 

 

For the nine months ended September 30, 2011

 

 

 

Previously

 

 

 

 

 

 

 

Reported

 

Adjustments

 

Restated

 

Cash flows from operating activities:

 

 

 

 

 

 

 

Consolidated net loss

 

(13,003

)

(1,041

)

(14,044

)

Deferred income taxes

 

(7,758

)

1,041

 

(6,717

)

Net cash provided by operating activities

 

56,067

 

 

56,067